Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Leukemia

  • Chapter
Cancer Neurology in Clinical Practice

Abstract

Neurologic complications are relatively common in patients with leukemia. They occur either as a result of direct dissemination of leukemia to the nervous system, or indirectly as a consequence of treatment. Leukemic cells usually infiltrate the leptomeninges, but rarely the brain parenchyma and peripheral nerves may be affected. Neurologic complications may also result from treatment-related neurotoxicity or bone marrow aplasia. This chapter focuses principally on the direct neurologic complications of leukemia, particularly leptomeningeal disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of acute leukaemias. Br J Haematol 1976; 33: 451–458.

    Article  PubMed  CAS  Google Scholar 

  2. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting–Airlie House Virginia, November 1997. J Clin Oncol 1999; 17: 3835–3849.

    PubMed  CAS  Google Scholar 

  3. Hayashi T, Onodera J, Mochizuki H, et al. Primary central nervous system leukemia with a novel chromosomal translocation. J Neurol Sci 1997; 151: 107–110.

    Article  PubMed  CAS  Google Scholar 

  4. Glass JP, Van Tassel P, Keating MJ, et al. Central nervous system complications of a newly recognized subtype of leukemia: AMML with a pericentric inversion of chromosome 16. Neurology 1987; 37: 639–644.

    Article  PubMed  CAS  Google Scholar 

  5. Haaxma-Reiche H. Neurologic complications of leukemia. In: Handbook of Clinical Neurology; Neuro-Oncology, Part III. Vecht Ch J, ed. Elsevier Science BV, Amsterdam, 1997, pp. 233–260.

    Google Scholar 

  6. Laport GF, Larson RA. Treatment of adult acute lymphoblastic leukemia. Seminars in Oncology 1997; 24: 70–82.

    PubMed  CAS  Google Scholar 

  7. Kantarjian HM, O’Brien S, Smith TL, et al. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol 2000; 18: 547–561.

    PubMed  CAS  Google Scholar 

  8. Löwenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med 1999; 17: 1051–1062.

    Article  Google Scholar 

  9. Kao SC, Yuh WT, Sato Y, Barloon TJ. Intracranial granulocytic sarcoma (chloroma): MR findings. Journal Computer Assisted Tomography 1987; 11: 938–941.

    Article  CAS  Google Scholar 

  10. Krishnamurthy M. Nusbacher N. Elguezabal A. Seligman BR. Granulocytic sarcoma of the brain. Cancer 1977; 39: 1542–1546.

    Article  PubMed  CAS  Google Scholar 

  11. Barnett MJ, Zussman WV. Granulocytic sarcoma of the brain: a case report and review of the literature. Radiology 1986; 160: 223–225.

    PubMed  CAS  Google Scholar 

  12. Parker K. Hardjasudarma M. McClellan RL. Fowler MR. Milner JW. MR features of an intracerebellar chloroma. Am J Neuroradiol 1996; 17: 1592–1594.

    PubMed  CAS  Google Scholar 

  13. Frohna BJ, Quint DJ. Granulocytic sarcoma (chloroma) causing spinal cord compression. Neuroradiology. 1993; 35: 509–511.

    Article  PubMed  CAS  Google Scholar 

  14. Kellie SJ, Waters KD. Extradural chloroma with spinal compression-an unusual presentation of acute myelogenous leukemia. Aust NZ J Med 1984; 14: 160–162.

    Article  CAS  Google Scholar 

  15. Wong MC. Krol G. Rosenblum MK. Occult epidural chloroma complicated by acute paraplegia following lumbar puncture. Ann Neuro 1992; 31: 110–112.

    Article  CAS  Google Scholar 

  16. Taguchi H, Sonobe H, Yamato K, et al. Central nervous system involvement of adult T-Cell leukemia-lymphoma with multinucleated giant cells in the brain, skin and kidney. Cancer 1993; 71: 133–137.

    Article  PubMed  CAS  Google Scholar 

  17. Le Bezu M, Pinaudeau Y, Poirier J, et al. Involvement of the nervous system in hairy cell leukemia. Arch Neurol 1985; 42: 839.

    Article  PubMed  Google Scholar 

  18. Wolfe DW, Scopelliti JA, Boselli BD. Leukemic meningitis in a patient with hairy cell leukemia. Cancer 1984; 54: 1085–1089.

    Article  PubMed  CAS  Google Scholar 

  19. Kimmel DW, Hermann RC, O’Neill BP. Neurologic complications of hairy cell leukemia. Arch Neurol 1984; 41: 1451–1455.

    Article  Google Scholar 

  20. Lowe J, Russell NH. Cerebral vasculitis associated with hairy cell leukemia. Cancer 1987; 60: 3025–3028.

    Article  PubMed  CAS  Google Scholar 

  21. Price RA, Johnson WW. The central nervous system in childhood leukemia: I. The arachnoid. Cancer 1973; 31: 520–533.

    Article  PubMed  CAS  Google Scholar 

  22. Pitner SE, Johnson WW. Chronic subdural hematoma in childhood acute leukemia. Cancer 1973; 32: 185–190.

    Article  PubMed  CAS  Google Scholar 

  23. Chamberlain MC. Spinal 111Indium-DTPA CSF flow studies in leptomeningeal metastasis. J Neuro-Oncol 1995; 25: 135–141.

    Article  CAS  Google Scholar 

  24. Haaxma-Reiche H, Piers DA, Beekhuis H. Normal cerebrospinal fluid dynamics A study with intraventricular injection of 111In-DPTA in leukemia and lymphoma without meningeal involvement. Arch Neurol 1989; 46: 997–999.

    Article  PubMed  CAS  Google Scholar 

  25. Yamauchi K, Umeda Y. Symptomatic intracranial haemorrhage in acute nonlymphoblastic leukaemia: analysis of CT and autopsy findings. J Neurol 1997; 244: 94–100.

    Article  PubMed  CAS  Google Scholar 

  26. Alajouanine T, Thurel R, Castaigne P, et al. Leucémie aigüe avec syndrome polynévritique et infiltration leucosique des nerfs. Rev Neurol 1949; 81: 249–261.

    Google Scholar 

  27. Haberland C, Ciprian M, Kucuk O, et al. Fulminant leukemic polyradiculoneuropathy in a case of B-Cell prolymphocytic leukemia. Cancer 1987; 60: 1454–1458.

    Article  PubMed  CAS  Google Scholar 

  28. Krendel DA, Albright RE, Graham DG. Infiltrative polyneuropathy due to acute monoblastic leukemia in hematologic remission. Neurology 1987; 37: 474–477.

    Article  PubMed  CAS  Google Scholar 

  29. Kuroda Y, Nakata H, Kakigi R, et al. Human neurolymphomatosis by adult T-cell leukemia. Neurology 1989; 39: 144–146.

    Article  PubMed  CAS  Google Scholar 

  30. Lachowski D, Koberda JL, DeLoughery TG, et al. Natural killer cell leukemia as a cause of peripheral neuropathy and meningitis: case report. Neurology 1998; 51: 640–641.

    Article  Google Scholar 

  31. Lekos A, Katirji B, Cohen ML, et al. Mononeuritis multiplex, a harbinger of acute leukemia in relapse. Arch Neurol 1994; 51: 618–622.

    Article  PubMed  CAS  Google Scholar 

  32. McLeod JG. Peripheral neuropathy associated with lymphomas, leukemias, and polycythemia vera. In: Peripheral Neuropathy. DyckPJ, Thomas PK, eds. W.B. Saunders, Philadelphia, 1993, pp. 1591–1598.

    Google Scholar 

  33. Nishi Y, Yufu Y, Shinomyia S, et al. Polyneuropathy in acute megakaryoblastic leukemia. Cancer 1991; 68: 2033–2036.

    Article  PubMed  CAS  Google Scholar 

  34. Phanthumchinda K, Intragumtornchai T, Kasantikul V. Guillain-Barré syndrome and optic neuropathy in acute leukemia. Neurology 1988; 38: 1324–1326.

    Article  PubMed  CAS  Google Scholar 

  35. Mahmoud HH, Rivera GK, Hancock ML, et al. Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia. N Engl J Med 1993; 329: 314–319.

    Article  PubMed  CAS  Google Scholar 

  36. Smith M, Arthur RD, Camitta B, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 1996; 14: 18–24.

    PubMed  CAS  Google Scholar 

  37. Lauer S, Shuster J, Kirchner P, et al. Prognostic significance of cerebrospinal fluid (CSF) lymphoblasts (LB) at diagnosis (dx) in children with acute lymphoblastic leukemia (ALL). Proc Am Soc Clin Oncol 1994; 13: 317.

    Google Scholar 

  38. Mahmoud H, Relling M, Liu Q, et al. Presence of leukemic blasts in cerebrospinal fluid (CSF) is predictive of central nervous (CNS) relapse in childhood lymphoblastic leukemia. Proc Am Soc Clin Oncol 1994; 13: 319.

    Google Scholar 

  39. Tubergen DG, Cullen JW, Boyett JM, et al. Blasts in CSF with a normal cell count do not justify alteration of therapy for acute lymphoblastic leukemia in remission: a Childrens Cancer Group study. J Clin Oncol 1994; 12: 273–278.

    PubMed  CAS  Google Scholar 

  40. Aaronson AG, Hajdu SI, and Melamed MR. Spinal fluid cytology during chemotherapy of leukemia of the central nervous system in children. Am J Clin Pathol 1975; 63: 528–537.

    PubMed  CAS  Google Scholar 

  41. Campana D, Coustan-Smith E, and Janossy G. The immunologic detection of minimal residual disease in acute leukemia. Blood 1990; 76: 163–171.

    PubMed  CAS  Google Scholar 

  42. Murai H, Choi Y, Hohmann P, et al. Detection of malignant clonotypes in CNS leukemia and lymphoma by very low input primary generic and family-specific gene amplification. Neurology 1996; 46: A247.

    Article  Google Scholar 

  43. Rhodes CH, Glantz MJ, Glantz L, et al. A comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis. Cancer 1996; 77: 543–548.

    Article  PubMed  CAS  Google Scholar 

  44. Pagani JJ, Libshitzi HI, Wallace S, et al. Central nervous system leukemia and lymphoma: computed tomographic manifestations. Am J NeuroRadiol 1981; 2: 397–403.

    Google Scholar 

  45. Freilich RJ, Krol G, DeAngelis LM. Neuroimaging and the cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol 1995; 38: 51–57.

    Article  PubMed  CAS  Google Scholar 

  46. Yousem DM, Patrone PM, Grossman RI. Leptomeningeal metastases: MR evaluation. J Comp Assoc Tomogr 1990; 14: 255–261.

    Article  CAS  Google Scholar 

  47. Jaeckle KA, Krol G, Posner JB. Evolution of computed tomographic abnormalities in leptomeningeal metastases. Ann Neurol 1985; 17: 85–89.

    Article  PubMed  CAS  Google Scholar 

  48. Schumacher DJ, Tien RD, Friedman H, Gadolinium enhancement of the leptomeninges caused by hydrocephalus: a potential mimic of leptomeningeal metastasis. Am J NeuroRadiol 1994; 15: 639–641.

    PubMed  CAS  Google Scholar 

  49. Brant-Zawadski M, Enzmann DR. Computed tomographic brain scanning in patients with lymphoma. Radiology 1978; 129: 67–71.

    Google Scholar 

  50. Ang P, and Virapongse C. Magnetic resonance imaging of spinal intradural granulocytic sarcoma. Magn Reson Imaging 1990; 8: 95–100.

    Article  PubMed  CAS  Google Scholar 

  51. Neglia JP, Meadows AT, Robison LL, et al. Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 1991; 325: 1330–1336.

    Article  PubMed  CAS  Google Scholar 

  52. Relling MV, Rubnitz JE, Rivera GK, et al. High incidence of secondary brain tumours after radiotherapy and antimetabolites. Lancet 1999; 354: 34–39.

    Article  PubMed  CAS  Google Scholar 

  53. Pochedly C. Prevention of meningeal leukemia. In: Hematology/ Oncology Clinics of North America, vol. 4, no. 5. W.B. Saunders, Philadelphia, 1990, pp. 951–969.

    Google Scholar 

  54. Aur JA, Simone J, Hustu HO, et al. Central nervous system therapy and combination chemotherapy of childhood lymphocytic leukemia. Blood 1971; 37: 272–281.

    PubMed  CAS  Google Scholar 

  55. Aur JA, Hustu HO, Verzosa MS, et al. Comparison of two methods of preventing central nervous system leukemia. Blood 1973; 42: 349–357.

    PubMed  CAS  Google Scholar 

  56. Nesbit ME, Sather HN, Robison LL, et al. Presymptomatic central nervous system therapy in previously untreated childhood acute lymphoblastic leukaemia: comparison of 1800 rad and 2400 rad. Lancet 1981; I: 461–465.

    Article  Google Scholar 

  57. Reiter A, Schrappe M, Ludwig W-D, et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BEM 86. Blood 1994; 84: 3122–3133.

    PubMed  CAS  Google Scholar 

  58. Bleyer WA. Central nervous system leukemia. In: Leukemia. Gunz FW, Henderson ES, eds. Grune and Stratton, New York, 1983, pp. 865–911.

    Google Scholar 

  59. Bleyer WA, Dedrick RL. Clinical pharmacology of intrathecal methotrexate. I. Pharmacokinetics in nontoxic patients after lumbar injection. Cancer Treat Rep 1977; 61: 703–708.

    PubMed  CAS  Google Scholar 

  60. Sullivan MP, Chen T, Dyment PG, et al. Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: a Pediatric Oncology Group study. Blood 1982; 60: 948–958.

    PubMed  CAS  Google Scholar 

  61. Clarkson BD, Hahgbin M, Murphy ML, et al. Prevention of central nervous system leukaemia in acute lymphoblastic leukaemia with prophylactic chemotherapy alone. In: CNS Complications of Malignant Disease. Whitehouse JMA, Kay HEM, eds. Macmillan Press, London, 1979, pp. 36–58.

    Google Scholar 

  62. Gee TS, Hahgbin M, Dowling MD, et al. Acute lymphoblastic leukemia in adults and children. Differences in response with similar therapeutic regimens. Cancer 1976; 37: 1256–1264.

    Article  PubMed  CAS  Google Scholar 

  63. Shapiro WR, Young DF, Mehta BM. Methotrexate; distribution in cerebrospinal fluid after intravenous, ventricular, and lumbar injections. N Engl J Med 1975; 293: 161–166.

    Article  PubMed  CAS  Google Scholar 

  64. Schauer P, Arlin ZA, Mertelsmann R, et al. Treatment of acute lymphoblastic leukemia in adults: results of the L-10 and L-10M protocols. J Clin Oncol 1983; 1: 462–470.

    PubMed  CAS  Google Scholar 

  65. Collins JM. Pharmacokinetics of intraventricular administration. J Neuro-Oncol 1983; 1: 283–291.

    Article  CAS  Google Scholar 

  66. Balis FM, Lester CM, Chrousos CP, et al. Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia. J Clin Oncol 1987; 5: 202–207.

    PubMed  CAS  Google Scholar 

  67. Jones B, Freeman AI, Shuster JJ. Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia. Med Pediatr Oncol 1991; 91: 269–275.

    Article  Google Scholar 

  68. Veerman AJP, Hählen K, Kamps WA, et. al. High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia: results of protocol ALL VI from the Dutch Childhood Leukemia Study Group. J Clin Oncol 1996; 14: 911–918.

    PubMed  CAS  Google Scholar 

  69. Pui C-H. Childhood leukemias. N Engl J Med 1995; 332: 1618–1630.

    Article  PubMed  CAS  Google Scholar 

  70. Steinherz P, Jereb B, Galicich J. Therapy of CNS leukemia with intraventricular chemotherapy and low-dose neuraxis radiotherapy. J Clin Oncol 1985; 3: 1217–1226.

    PubMed  CAS  Google Scholar 

  71. Kamps WA, Bökkerink JPM, Hählen K, et al. Intensive treatment of children with acute lymphoblastic leukemia according to ALLBFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group protocol ALL-7 (1988–1991). Blood 1999; 94: 1226–1236.

    PubMed  CAS  Google Scholar 

  72. Krance RA, Newman EM, Ravindranath Y, et al. A pilot study of intermediate-dose Methotrexate and Cytosine Arabinoside, “Spread-Out” or “Up-Front,” in continuation therapy for childhood non-T, non-B acute lymphoblastic leukemia. Cancer 1991; 67: 550–556.

    Article  PubMed  CAS  Google Scholar 

  73. Pullen J, Boyett J, Shuster J, et al. Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with a B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol 1993; 11: 839–849.

    PubMed  CAS  Google Scholar 

  74. Camilla B, Mahoney D, Leventhal B, et al. Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia: a Pediatric Oncology Group study. J Clin Oncol 1994; 12: 1383–1389.

    Google Scholar 

  75. Gaynon PS, Steinherz PG, Bleyer WA, et al. Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group study CCG-106. J Clin Oncol 1993; 11: 2234–2242.

    PubMed  CAS  Google Scholar 

  76. Patte C, Philip T, Rodary C, et al. High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol 1991; 9: 123–132.

    PubMed  CAS  Google Scholar 

  77. Reiter A, Schrappe M, Ludwig W-D, et al. Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: report of three consecutive studies of the BFM Group. Blood 1992; 80: 2471–2478.

    PubMed  CAS  Google Scholar 

  78. Schwenn MR, Blattner SR, Lynch E, et al. HiC-COM: a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitts lymphoma and B-cell acute lymphoblastic leukemia. J Clin Oncol 1991; 9: 133–138.

    PubMed  CAS  Google Scholar 

  79. Pullen J, Shuster JJ, Link M, et al. Significance of commonly used prognostic factors differ for children with T cell acute lymphocytic leukemia (ALL) as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study. Leukemia 1999; 13: 1696–1707.

    Article  PubMed  CAS  Google Scholar 

  80. Conter V, Schrappe M, Arid, M, et al. for the Associazone Italiana Ematologia Oncologia Pediatrica and the Berlin-FrankfurtMünster Groups. Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. J Clin Oncol 1997; 15: 2786–2791.

    PubMed  CAS  Google Scholar 

  81. Reaman GH, Sposto R, Sensel MG, et al. Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children’ s Cancer Group. J Clin Oncol 1999; 17: 445–455.

    PubMed  CAS  Google Scholar 

  82. Nachman J, Sather HN, Cherlow JM, et al. Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children’ s Cancer Group. J Clin Oncol 1998; 16: 920–930.

    PubMed  CAS  Google Scholar 

  83. Pui C-H, Mahmoud HH, Rivera GK, et al. Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia. Blood 1998; 92: 411–415.

    PubMed  CAS  Google Scholar 

  84. Armitage JO, Burns CP. Remission maintenance of adult acute lymphoblastic leukemia. Med Pediatr Oncol 1977; 3: 53–58.

    Article  PubMed  CAS  Google Scholar 

  85. Omura GA, Moffitt S, Vogler WR, et al. Combination chemotherapy of adult acute lymphoblastic leukemia with randomized central nervous system prophylaxis. Blood 1980; 55: 199–204.

    PubMed  CAS  Google Scholar 

  86. Willemze ER, Drenthe-Schonk AM, van Rossum J, et al. Treatment of acute lymphoblastic leukaemia in adolescents and adults: comparison of two schedules for CNS leukaemia prophylaxis. Scand J Haematol 1980; 24: 421–426.

    Article  Google Scholar 

  87. Haaxma-Reiche H, Daenen S. Acute lymphoblastic leukemia in adults: results of intraventricular maintenance chemotherapy for central nervous system prophylaxis and treatment. Eur J Cancer Clin Oncol 1988; 24: 615–620.

    Article  PubMed  CAS  Google Scholar 

  88. Dekker AW, van `t Veer MB, Sizoo W, et al. for the Dutch HematoOncology Research Group. Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. J Clin Oncol 1997;15:476–482.

    Google Scholar 

  89. Cortes J, O’Brien SM, Pierce S, et al. The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia. Blood 1995; 86: 2091–2097.

    PubMed  CAS  Google Scholar 

  90. Price RA. Histopathology of central nervous system leukemia. In: Mod Probl Paediatr vol. 16: Acute Childhood Leukemia, Karger, Basel, 1975, pp. 80–98.

    Google Scholar 

  91. Meyer RJ, Ferreira PPC, Cuttner J, et al. Central nervous system involvement at presentation in acute granulocytic leukemia. Am J Med 1980; 68: 691–694.

    Article  PubMed  CAS  Google Scholar 

  92. Peterson BA, Brunning RD, Bloomfield CD, et al. Central nervous system involvement in acute nonlymphocytic leukemia. Am J Med 1987; 83: 464–470.

    Article  PubMed  CAS  Google Scholar 

  93. Pui C-H, Dahl GV, Kalwinsky DK, et al. Central nervous system leukemia in children with acute nonlymphoblastic leukemia. Blood 1985; 66: 1062–1067.

    PubMed  CAS  Google Scholar 

  94. Haaxma-Reiche H, Daenen S, Witteveen RJW. Experiences with the Ommaya reservoir for prophylaxis and treatment of the central nervous system in adult myelocytic leukemia. Blut 1988; 57: 351–355.

    Article  PubMed  CAS  Google Scholar 

  95. Nachman J, Sather HN, Buckley JD, et al. Young adults 16–21 years of age at diagnosis entered on Childrens Cancer Group acute lymphoblastic leukemia and acute myeloblastic leukemia protocols. Cancer 1993; 71: 3377–3385.

    Article  PubMed  CAS  Google Scholar 

  96. Ravindranath Y, Steuber CP, Krischer J, et al. High-dose cytarabine for intensification of early therapy of childhood acute myeloid leukemia: a Pediatric Oncology Group study. J Clin Oncol 1991; 9: 572–580.

    PubMed  CAS  Google Scholar 

  97. Steuber CP, Civin C, Krischer J, et al. A comparison of induction and maintenance therapy for acute non-lymphocytic leukemia in childhood: results of a Pediatric Oncoloy Group study. J Clin Oncol 1991; 9: 247–258.

    PubMed  CAS  Google Scholar 

  98. Wells RJ, Woods WG, Buckley JD, et al. Treatment of newly diagnosed children and adolescents with acute myeloid leukemia: a Childrens Cancer Group study. J Clin Oncol 1994; 12: 2367–2377.

    PubMed  CAS  Google Scholar 

  99. Ritchey AK, Pollock BH, Lauer SJ, et al. Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a Pediatric Oncology Group Study. J Clin Oncol 1999; 17: 3745–3752.

    PubMed  CAS  Google Scholar 

  100. Bleyer WA, Poplack DG. Intraventricular versus intralumbar methotrexate for central nervous system leukemia: prolonged remission with the Ommaya reservoir. Med Pediatr Oncol 1979; 6: 207–213.

    Article  PubMed  CAS  Google Scholar 

  101. lacoangeli M, Roselli R, Pagano L, et al. Intrathecal chemotherapy for treatment of overt meningeal leukemia: comparison between intraventricular and traditional intralumbar route. Ann Oncol 1995; 6: 377–382.

    Google Scholar 

  102. Lishner M, Scheinbaum R, Messner HA. Intrathecal vancomycin in the treatment of Ommaya reservoir infection by staphylococcus epidermidis. Scand J Infect Dis 1991; 23: 101–104.

    Article  PubMed  CAS  Google Scholar 

  103. Machado M, Salcman M, Kaplan RS, et al. Expanded role of the cerebrospinal fluid reservoir in neurooncology: indications, causes of revision, and complications. Neurosurgery 1985; 17: 600–603.

    Article  PubMed  CAS  Google Scholar 

  104. Sundaresan N, Suite NDA. Optimal use of the Ommaya reservoir in clinical oncology. Oncology 1989; 3: 15–23.

    PubMed  CAS  Google Scholar 

  105. Bigner S. Cerebrospinal fluid (CSF) cytology: current status and diagnostic applications. J Neuropathol Exp Neuro11992; 51: 235–245.

    Google Scholar 

  106. Stone JA, Castillo M, Mukherji SK. Leukoencephalopathy complicating an Ommaya reservoir and chemotherapy. Neuroradiology 1999; 41: 134–136.

    Article  PubMed  CAS  Google Scholar 

  107. Chamberlain MC, Kormanik PA, Barba D. Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases. J Neurosurg 1997; 87: 694–699.

    Article  PubMed  CAS  Google Scholar 

  108. Chamberlain MC. Radioisotope CSF flow studies in leptomeningeal metastases. J Neuro-Oncol 1998; 38: 135–140.

    Article  CAS  Google Scholar 

  109. Mason WP, Yeh SDJ, DeAngelis LM. Mindium-diethylenetriamine pentaacetic acid cerebrospinal fluid flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases. Neurology 1998; 50: 438–443.

    Article  PubMed  CAS  Google Scholar 

  110. Sullivan MP, Moon TE, Trueworthy R, et al. Combination intrathecal therapy for meningeal leukemia: two versus three drugs. Blood 1977; 50: 471–479.

    PubMed  CAS  Google Scholar 

  111. Metz O, Schickedanz H, Mohr F, et al. Therapieergebnisse mit dem Ommaya-Reservoir. Kinderärztl Praxis 1985; 53: 269–276.

    CAS  Google Scholar 

  112. Haghbin M, Galicich JH. Therapy of CNS leukemia, continued; Use of the Ommaya reservoir in the prevention and treatment of CNS leukemia. Am J Pediatr Hematol Oncol 1979; 1: 111–117.

    PubMed  CAS  Google Scholar 

  113. Winick NJ, Smith SD, Shuster J, et al. Treatment of CNS relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol 1993; 11: 271–278.

    PubMed  CAS  Google Scholar 

  114. Kun LE, Camitta BM, Mulhern RK, et al. Treatment of meningeal relapse in childhood acute lymphoblastic leukemia. I. Results of craniospinal irradiation. J Clin Oncol 1984; 2: 359–364.

    PubMed  CAS  Google Scholar 

  115. Mandell LR, Steinherz P, Fuks Z. Delayed central nervous system (CNS) radiation in childhood CNS acute lymphoblastic leukemia, results of a pilot trial. Cancer 1990; 66: 447–450.

    Article  PubMed  CAS  Google Scholar 

  116. Kim TH, Ramsay NK, Steves RA, et al. Intermittent central nervous system irradiation and intrathecal chemotherapy for central nervous system leukemia in children. Int J Rad Oncol Biol Phys 1987; 13: 1451–1455.

    Article  CAS  Google Scholar 

  117. Bleyer WA, Poplack DG, Simon RM, et al. “Concentration x Time” methotrexate via a subcutaneous reservoir: a less toxic regimen for intraventricular chemotherapy of central nervous system neoplasms. Blood 1978; 51: 835–842.

    PubMed  CAS  Google Scholar 

  118. Moser AM, Adamson PC, Gillespie AJ, et al. Intraventricular concentration times time (CxT) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma. Cancer 1999; 85: 511–516.

    Article  PubMed  CAS  Google Scholar 

  119. Glantz MJ, LaFollette S, Jaeckle KA, et al. Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol 1999; 17: 3110–3116.

    PubMed  CAS  Google Scholar 

  120. Pizer B, Papanastassiou V, Hancock J, et al. A pilot study of monoclonal antibody targeted radiotherapy in the treatment of central nervous system leukaemia in children. Br J Haematol 1991; 77: 466–472.

    Article  PubMed  CAS  Google Scholar 

  121. Balis FM, Savitch JL, Bleyer WA, et al. Remission induction of meningeal leukemia with high-dose intravenous methotrexate. J Clin Oncol 1985; 3: 485–490.

    PubMed  CAS  Google Scholar 

  122. Blaney SM, Balis FM, Poplack DG. Pharmacologic approaches to the treatment of meningeal malignancy. Oncology 1991; 5: 107–116.

    PubMed  CAS  Google Scholar 

  123. Mahoney DH, Shuster JJ, Nitscke R, et al. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy: a Pediatric Oncology Group study. J Clin Oncol 1998; 16: 1712–1722.

    PubMed  CAS  Google Scholar 

  124. Surtees R, Clelland, Hann I. Demyelination and single-carbon transfer pathway metabolites during the treatment of acute lymphoblastic leukemia: CSF studies. J Clin Oncol 1998; 16: 1505–1511.

    PubMed  CAS  Google Scholar 

  125. Laporte JP, Godefroy W, Verily A, et al. Intrathecal mitozantrone. Lancet 1985;ii:160.

    Google Scholar 

  126. Zuiable A, Maitland J, Nandi A, et al. Intrathecal mitozantrone for resistant leukaemia. Lancet 1985;ii:1060–1061.

    Google Scholar 

  127. Blasberg RG, Patlak CS, Shapiro WR. Distribution of methotrexate in the cerebrospinal fluid and brain after intraventricular administration. Cancer Treat Rep 1977; 61: 633–641.

    PubMed  CAS  Google Scholar 

  128. Lankelma J, Lippens RJJ, Drenthe-Schonk A, et al. Change in transfer rate of methotrexate from spinal fluid to plasma during intrathecal therapy in children and adults. Clin Pharmacokinetics 1980; 5: 465–475.

    Article  CAS  Google Scholar 

  129. Strother DR, Glynn-Barnhart A, Kovnar E, et al. Variablity in the disposition of intraventricular methotrexate: a proposal for rational dosing. J Clin Oncol 1989; 7: 1741–1747.

    PubMed  CAS  Google Scholar 

  130. Hill JM, Komblith AB, Jones D, et al. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation. Cancer 1998; 82: 208–218.

    Article  PubMed  CAS  Google Scholar 

  131. Lesnik PG, Ciesielski KT, Hart BL, et al. Evidence for cerebellar-frontal subsystem changes in children treated with intrathecal chemotherapy for leukemia. Arch Neurol 1998; 55: 1561–1568.

    Article  PubMed  CAS  Google Scholar 

  132. Baker WJ, Royer GL Jr, Weiss RB. Cytarabine and neurologic toxicity. J Clin Oncol 1991; 9: 679–693.

    PubMed  CAS  Google Scholar 

  133. Openshaw H, Slatkin NE, Stein AS, et al. Acute polyneuropathy after high dose cytosine arabinoside in patients with leukemia. Cancer 1996; 78: 1899–1905.

    Article  PubMed  CAS  Google Scholar 

  134. Bernat JL. Intraspinal steroid therapy. Neurology 1981; 31: 168–171.

    Article  PubMed  CAS  Google Scholar 

  135. Bender RA, Bleyer WA, Frisby SA, et al. Alteration of methotrexate uptake in human leukemia cells by other agents. Cancer Res 1975; 35: 1305–1308.

    PubMed  CAS  Google Scholar 

  136. Poplack DG, Bleyer WA, and Pizzo PA. Experimental approaches to the treatment of CNS leukemia. Am J Pediatr Hematol Oncol 1979; 1: 141–149.

    PubMed  CAS  Google Scholar 

  137. Ito C, Evans WE, McNinch L, et al. Comparative cytotoxicity of dexamathasone and prednisolone in childhood acute lymphoblastic leukemia. J Clin Oncol 1996; 14: 2370–2376.

    PubMed  CAS  Google Scholar 

  138. Graus F, Saiz A, Sierra J, et al. Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia. Neurology 1996; 46: 1004–1009.

    Article  PubMed  CAS  Google Scholar 

  139. Antonini G, Ceschin V, Morino S, et al. Early neurologic complications following bone marrow transplant for leukemia. Neurology 1998; 50: 1441–1445.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Hanny Haaxma-Reiche MD, PHD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Neurology, University of Virginia Medical Center, Charlottesville, VA, USA

    David Schiff MD

  2. Center for Neuro-Oncology Dana-Farber Cancer Institute; and Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA

    Patrick Y. Wen MD

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Haaxma-Reiche, H. (2003). Leukemia. In: Schiff, D., Wen, P.Y. (eds) Cancer Neurology in Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-317-0_24

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-317-0_24

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-4703-4

  • Online ISBN: 978-1-59259-317-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation